Pharmaceutical

After joining multiple other drugmakers on the U.S. investment bandwagon earlier this year, Gilead Sciences is providing further details on where it p...

A new awareness-raising effort from Incyte is aimed at giving doctors an up-close look at the emotional and physical challenges their patients with hi...

Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing platform. The FDA has granted th...

Dive Brief: More than 1,000 current and former HHS employees are calling on Robert F. Kennedy, Jr. to resign as Health and Human Services secretary, a...

Dive Brief: Argo Biopharma said Wednesday it’s entered a new collaboration with Novartis to develop RNA medicines for cardiovascular diseases. The dea...

Dive Brief: An experimental RNA editing medicine from Wave Life Sciences helped study participants with a rare liver and lung disease produce a protei...

For the past four years or so, veteran drug hunters Josh Bilenker and Jeff Engelman have kept tightly under wraps the details of their latest project,...

Biohaven’s top executive said his team is well-prepared to sell a therapy that could be not only the first approved medicine for a group of rare brain...

“It hasn’t been an obvious linear path,” Morgan Biles says about the road that has led to her current position as a senior copywriter at Weber Shandwi...

Trial explores regenerative macrophage therapy for liver disease Trial explores regenerative macrophage therapy for liver disease